Apixaban ethyl ester

Name: Apixaban ethyl ester
Brand: MedChemExpress
SKU: HY-75680
Rating: 4.5 (0 reviews)

Cat. No.: HY-75680 Purity: 99.89%: Data Sheet
COA

SDS
Handling Instructions
FAQs
Technical Support

Apixaban ethyl ester is a key intermediate in the synthesis of FXa inhibitors, which is used to study the inhibitory activity against venous thrombosis.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

Apixaban ethyl ester 화학구조

CAS No. : 503614-91-3

사이즈	재고	수량
무료 샘플 (0.1 - 0.2 mg)	지금 신청하기
무료 샘플 (0.1 - 0.2 mg)	지금 신청하기
5 mg	해외재고보유	Estimated Time of Arrival: December 31
10 mg	해외재고보유	Estimated Time of Arrival: December 31
25 mg	해외재고보유	Estimated Time of Arrival: December 31
50 mg	해외재고보유	Estimated Time of Arrival: December 31
100 mg	해외재고보유	Estimated Time of Arrival: December 31
200 mg	견적 받기
500 mg	견적 받기

or 대량구매 문의

* 장바구니에 담기 전 물품의 수량을 선택해 주십시오.

This product is a controlled substance and not for sale in your territory.

고객리뷰

Based on 1 Customer Validation

Featured Recommendations

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

Biological Activity
순도&문서
References
고객리뷰

제품 설명

Apixaban ethyl ester is a key intermediate in the synthesis of FXa inhibitors, which is used to study the inhibitory activity against venous thrombosis^[1].

In Vitro

Apixaban ethyl ester (Compound 11a) is the key intermediate in the synthesis of FXa inhibitors^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

분자량

488.54

화학식

C₂₇H₂₈N₄O₅

CAS No.

503614-91-3

Appearance

Solid

Color

White to yellow

SMILES

O=C(N(C(C=C1)=CC=C1N(CCCC2)C2=O)CC3)C4=C3C(C(OCC)=O)=NN4C5=CC=C(OC)C=C5

선적

Room temperature in continental US; may vary elsewhere.

보관

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

순도&문서

Purity: 99.91%

Select Batch:

Data Sheet (272 KB) SDS (394 KB)

COA (256 KB) HNMR (236 KB) RP-HPLC (6304 KB) LCMS (1820 KB)

Handling Instructions (2659 KB)

References

[1]. Wang Y, et al. Design, synthesis, and structure–activity relationship of novel and effective apixaban derivatives as FXa inhibitors containing 1, 2, 4-triazole/pyrrole derivatives as P2 binding element[J]. Bioorganic & Medicinal Chemistry, 2016, 24(21): 5646-5661. [Content Brief]